FDA has made labeling updates for the preparation of vinca alkaloids, a group of chemotherapy agents that includes vincristine sulfate injection, vinblastine sulfate (for) injection, and vinorelbine tartrate injection.
Despite increases in overall suicide rates in the United States during the past two decades, cancer-related suicides declined by 2.8% per year, according to a new study by the American Cancer Society.
A first-of-its-kind randomized clinical trial found that patients with pancreatic cancer didn't live any longer than expected after receiving pre-operative chemotherapy from either of the two standard regimens.
Researchers at MD Anderson Cancer Center have developed the first comprehensive framework to classify small-cell lung cancer into four unique subtypes, based on gene expression, and have identified potential therapeutic targets for each type.
A study of patients with gynecologic cancers in Brazil found that most patients present with advanced disease, which leads to lower survival rates.
Stand Up To Cancer has announced $3.25 million in grants from four nonprofits to fund research to find new treatments for head and neck cancers.
Adekunle “Kunle” Odunsi, an expert in immunotherapy and vaccine therapy for cancer, was named director of the University of Chicago Medicine Comprehensive Cancer Center effective March 1.
Joel Helmke was named chief operating officer of Fox Chase Cancer Center.
Manmeet Ahluwalia was named deputy director, chief scientific officer and chief of solid tumor medical oncology at Baptist Health's Miami Cancer Institute.
Rachel Adams Greenup was named associate professor of surgery (oncology) and section chief of breast surgery for the Department of Surgery at Yale School of Medicine.
